Established 1999
123jump.com - U.S. Financial Information Archive: 90,000 Annual and 10-K reports – 20,000 Global news stories - 3,500 IPO reports - 1,700 - Earnings Calls – 320 Fund Interviews – 10-year Annual earnings on 4,500 stocks – 20 Quarterly earnings on 3,600 stocks – 1,800 IPO prospectuses – 1,200 Economic data releases
     
   
 

Tandem Healthcare(TAND)

 
123Jump Rating:   Underwriters: Merrill Lynch & Co.
      Citigroup
Status: Withdrawn  
 
Address: FiledDate: 10/07/2005
     
  Filed Price Range ($):
       
Telephone: Filed Offer Amount ($ Million): $0.00
       
Fax: Shares Offered (Millions):
       
Websites: Shares Outstanding (Millions):
       
Management: IPO Date:
     
  Final Offer Price ($): $0.00
       
Industry: Healthcare Final Offer Size (Millions of Shares): 0.00
       
Employees: Final Offer Amount ($ Million): $0.00
       
Competitors: S-1 Forms:
     
   
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Company Links
Executives Products Services
Major Stock Holders   (Prior To Offering)

Name

Carla G. Naegele NA NA NA NA NA NA
Eugene R. Curcio NA NA NA NA NA NA
Joseph D. Conte NA NA NA NA NA NA
Lawrence R. Deering NA NA NA NA NA NA
Rosemary L. Corsetti NA NA NA NA NA NA

Business Environment

The long-term healthcare industry is a highly fragmented industry, comprised of approximately 16,000 skilled nursing facilities with approximately 1.8 million licensed beds as of June 2005, according to AHCA. As of June 30, 2005, the five largest public long-term healthcare companies controlled less than 10% of these skilled nursing facilities. The underlying trends within the long-term healthcare industry are positive and are characterized by an increasing demand for long-term healthcare services coupled with an industry-wide reduction in the supply of long-term healthcare beds.

The demand for long-term healthcare services will continue to grow due to an aging population and increased life expectancies. The Centers for Medicare and Medicaid Services or, CMS predicts that nursing home expenditures, which include traditional skilled nursing care and specialty medical services, will grow from approximately $103.7 billion in 2002 to approximately $174.0 billion in 2012. A major contributor to this growth is the rapidly aging United States population. According to the United States Census Bureau, the number of Americans aged 85 or older is expected to more than double from approximately 4.3 million in 2000 to approximately 9.6 million in 2030.

Company Strategy
The Company is a leading provider of long-term healthcare services through its regionally concentrated networks of long-term healthcare facilities and portfolio of ancillary services.

Product/Services Portfolio
The Company’s core business is to provide facility based long-term healthcare services, which consist of the following services: long-term skilled nursing care, short-term transitional therapy and rehabilitation care, Alzheimer’s care, assisted living services, independent living services. The Company provides medical and rehabilitation programs for patients recovering from major surgery, severe injury, or serious cardiovascular, respiratory, infectious, endocrine or neurological illnesses, with a primary goal of returning patients home or to a similar environment.

The Company provides innovative services and facilities to care for Alzheimer’s patients in early, middle and advanced stages of the disease. Trained staffs provide specialized care and programming for persons with Alzheimer’s or related disorders in the Company’s facilities and in dedicated units within many of its skilled nursing centers.

The Company has a number of assisted living facilities, as well as units within it skilled nursing centers, dedicated to providing personal care services and assistance with general activities, including facilities which care for persons with Alzheimer’s or related disorders. The Company uses a comprehensive resident assessment to help determine the appropriate package of services desired or required by each resident. A majority of the Company’s assisted living facilities are located on campuses with its skilled nursing facilities.

All of the Company’s independent living facilities are located on its campuses, which allow residents of the independent living facilities to avail themselves of those services provided in the Company’s skilled nursing or assisted living facilities. As of June 30, 2005, the Company operated five independent living facilities.

The Company currently provides rehabilitation therapy services to approximately 250 facilities in 12 states, including some of its own facilities, through the Company’s rehabilitation therapy division. Rehabilitation therapy services consist of delivering physical, occupational and speech therapy services primarily in the skilled nursing setting. Included in other are the following ancillary services: institutional pharmacy, mobile diagnostic imaging, hospice, and other corporate items.

As of June 30, 2005 the Company’s institutional pharmacy operations, operated through its CoastalMed Pharmacy division, provided institutional pharmacy services to 20 third-party and 16 Tandem facilities in Florida. Mobile diagnostic imaging services consist of providing portable X-ray and cardiac monitoring services to long term care facilities, utilizing teleradiology technology. The Company is currently the largest provider of mobile diagnostic imaging services in Michigan and is in the process of entering into Ohio and Pennsylvania markets.

Investment Analysis
Total revenue increased $59.5 million, or 31.7%, to $247.4 million for the six months ended June 30, 2005 from $187.8 million for the six months ended June 30, 2004.

Rehabilitation therapy revenue increased $22.9 million to $25.0 million for the six months ended June 30, 2005 from $2.1 million for the six months ended June 30, 2004.

Operating expenses increased $37.3 million, or 34.1%, to $146.7 million for the six months ended June 30, 2005 from $109.4 million for the six months ended June 30, 2004, compared to the increase in total revenue of 31.7%.

General and administrative expenses and provision for bad debts increased $8.7 million, or 15.8%, to $63.9 million for the six months ended June 30, 2005 from $55.2 million for the six months ended June 30, 2004.

Income Data 
Year Revenues Costs Oper Income Taxes Net Income EPS
2002 299089 297197 0.00 658 1234 -2.810000000000000053290705182007513940334320068359375
2003 332553 339838 0.00 4200 -11485 -13.96000000000000085265128291212022304534912109375
2004 379710 372376 0.00 -4119 11453 3.729999999999999982236431605997495353221893310546875
2005 247381 235199 0.00 4291 7891 2.339999999999999857891452847979962825775146484375
*As of period Ended June 30, 2005

Balance Sheet Data

Year

Cash Acct Recv. Inventory Total Cur Assets Total Cur Liability PPE Total Assets LT Debt SH Equity
2003 8083 46774 1742 69427 71019 112212 231569 121543 -24402
2004 2719 43967 2019 76855 73410 135674 321017 177942 -12261
2005 3653 73170 1940 103700 98667 181294 435197 242283 1383
*As of period Ended June 30, 2005

Cash Flow Summary

Year

Net Cash-Ops Net Cash-Inv Net Cash-Fin Net Change
2002 9219 -33612 22638 -1755
2003 15963 -33618 23684 6029
2004 23063 -94355 65928 -5364
2005 -1650 -89504 92088 934
*As of period Ended June 30, 2005
 

 

© 1999-2008 123jump.com. All rights reserved